Boehringer Ingelheim

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with more than 54,000 employees in 76 countries. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.

Source: https://www.boehringer-ingelheim.com/

dabigatranPradaxa

direct thrombin inhibitor

Pradaxa (dabigatran etexilate) is an oral direct thrombin inhibitor from Boehringer Ingelheim. By blocking thrombin, the enzyme that forms clots, it reduces stroke risk in atrial fibrillation and treats or prevents deep vein thrombosis and pulmonary embolism.

When a clot forms, an enzyme called thrombin turns soluble proteins into the sticky fibrin mesh that holds the clot together. Dabigatran binds thrombi

empagliflozinJardiance

SGLT2 inhibitor

Jardiance (empagliflozin) is an SGLT2 inhibitor from Boehringer Ingelheim. It lowers blood sugar by letting glucose leave through the urine, and it also protects the heart and kidneys, reducing heart failure hospitalisation and kidney disease progression.

The kidneys filter blood constantly and normally reclaim all glucose. Empagliflozin blocks SGLT2, the transporter that recovers most of that glucose,

tiotropium bromideSpiriva

long-acting muscarinic antagonist (anticholinergic)

Tiotropium bromide (Spiriva) is an inhaled medicine that relaxes the muscles around the airways by blocking muscarinic receptors. It is used once daily as long-term maintenance treatment to open the airways and reduce flare-ups in people with chronic obstructive pulmonary disease.

Tiotropium is an inhaled medicine that blocks muscarinic receptors, mainly the M3 type, on the smooth muscles surrounding the airways. Normally, a che

3 medicines explained